Efficacy and Safety of Tocilizumab in the Treatment of Ocular Manifestations in Giant Cell Arteritis

Vision loss in GCA is an ophthalmic emergency that requires prompt medical intervention. The goal of the treatment is to preserve the remaining vision and prevent further systemic complications. Corticosteroids are the first-line treatment for GCA but are prone to cause iatrogenic side effects. In this review, we discuss the role of other immunosuppressant medications, especially Tocilizumab in controlling cases of GCA with ocular involvement and review the literature on the indication, guidelines of administration, and safety of Tocilizumab.